Frans Van de Werf
- Endocrinology, Diabetes and Metabolism top 0.5%
- Molecular Biology top 10%
- Surgery top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Oncology top 10%
- Co-authors
- Paul W. ArmstrongRury R. HolmanJennifer B. GreenEric D. PetersonJohn B. BuseEberhard StandlJohn M. LachinDarren K. McGuire
- Topics
- Diabetes Treatment and Management (10 papers)Diabetes Management and Research (5 papers)Antiplatelet Therapy and Cardiovascular Diseases (3 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Frans Van de Werf
13 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Endocrinology, Diabetes and Metabolism 1.9k
- Molecular Biology 733
- Surgery 666
- Cardiology and Cardiovascular Medicine 611
- Oncology 313
Countries citing papers authored by Frans Van de Werf
This map shows the geographic impact of Frans Van de Werf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frans Van de Werf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frans Van de Werf more than expected).
Fields of papers citing papers by Frans Van de Werf
This network shows the impact of papers produced by Frans Van de Werf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frans Van de Werf. The network helps show where Frans Van de Werf may publish in the future.
Co-authorship network of co-authors of Frans Van de Werf
This figure shows the co-authorship network connecting the top 25 collaborators of Frans Van de Werf. A scholar is included among the top collaborators of Frans Van de Werf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frans Van de Werf. Frans Van de Werf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 16 | |
| 4 | 2 | |
| 5 | 49 | |
| 6 | 25 | |
| 7 | 4 | |
| 8 | Assessing the safety of sitagliptin in elderly participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) | 1 |
| 9 | 167 | |
| 10 | Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetesbreakdown → | 1866 |
| 11 | Diabetes doubles the risk of death among patients presenting with acute coronary syndromes: insights from SYMPHONY, a large international trial | 1 |
| 12 | 111 | |
| 13 | 1 | |
| 14 | Compensatory Hyperkinesis : The Ejection Fraction 'Equalizer' after MI | 0 |
| 15 | 10 | |
| 16 | 27 |
About Frans Van de Werf
Frans Van de Werf is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Gastroenterology, having authored 16 papers that have together received 2.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Cardiology and Cardiovascular Medicine (611 citations) and Pharmacology (267 citations). Frans Van de Werf has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Paul W. Armstrong, Rury R. Holman, Jennifer B. Green, Eric D. Peterson, John B. Buse, Eberhard Standl, John M. Lachin, Darren K. McGuire, Michael Pencina and M. Angelyn Bethel. Their work appears in journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.